
Reset all filters
01 3AbbVie Corporation
Reset all filters
01 12567298
02 12789109
03 12849369
Reset all filters
01 3DEOXYCHOLIC ACID
Reset all filters
01 3SOLUTION
Reset all filters
01 12025-05-19
02 12028-06-18
03 12032-09-21
Patent Expiration Date : 2032-09-21
Date Granted : 2015-06-02
Brand Name : BELKYRA
Patent Number : 2849369
Filing Date : 2012-09-21
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-09-21
Date Granted : 2015-06-02
Patent Expiration Date : 2025-05-19
Date Granted : 2013-07-09
Brand Name : BELKYRA
Patent Number : 2567298
Filing Date : 2005-05-19
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-05-19
Date Granted : 2013-07-09
Patent Expiration Date : 2028-06-18
Date Granted : 2015-10-06
Brand Name : BELKYRA
Patent Number : 2789109
Filing Date : 2008-06-18
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-06-18
Date Granted : 2015-10-06